Fullscale_Intervention Study: Genetic Risk Communication in Coronary Heart Disease and Wearables

NCT05789966 | Not Yet Recruiting

• 1 other identifier: Fullscale_CHD_RCT
• Study Type: interventional
• Target: 414
• Locations: 0 countries
• Sites: N/A

Brief Summary

Background: This study aims to determine the effects of communicating genetic risk for Coronary Heart Disease (CHD) alone or in combination with goal setting and prompts from a wearable device on objectively measured sedentary time (ST) in East Asians. It is hypothesized that this combination will lead to significant favorable changes in objectively ST, and that such changes will be more likely to be sustained over 6-month follow-up. Methods: In a parallel group, randomized controlled trial, a total 414 individuals of East Asians aged over 60years will be allocated into one of three groups: 1 control and 2 intervention groups. Blood samples will be used for estimation of CHD genetic and analysis of metabolic risk markers. Genetic risk for CHD will be estimated based on recently identified 79 SNPs (associated with CHD for East Asians) using an established methodology. Questionnaires and physical measurement will be administered at Before and after the 12-month intervention and at 6-month follow-up. Each group will receive a Fitbit device. Both intervention groups will be given CHD genetic risk estimates along with lifestyle advice but one of them will additionally use Fitbit's step-goal setting and prompt functions. The primary outcome is objectively measured sedentary time. Secondary outcomes include objectively measured MVPA, calories burned, and five intermediate metabolic risk markers (total cholesterol/HDL-C/LDL-C/triglycerides).

Conditions

Fitness Trackers; Sedentary Time; Genetic Predisposition to Disease; Coronary Heart Disease

Keywords

Coronary Heart Disease; Genetic risk; Sedentary Time; Wearable Technology; Randomized Controlled Trial

Outcome Measures

Primary Outcomes (1)

• Changes in ST (average, in minutes/day) between baseline and Immediate post-intervention, between baseline and 12-month post-intervention, and between baseline and 6-month follow-up

  ST (average, in minutes/day) will be objectively measured by the Fitbit tracker.

  Baseline, 12-month post-intervention, 6-month follow-up

Secondary Outcomes (8)

• Changes in five activity indicators (steps, 'sedentary minutes', 'lightly active minutes', calories burn, and sleep time)

  Baseline, 12-month post-intervention, 6-month follow-up

• Changes in four CHD markers (total cholesterol/HDL-C/LDL-C/triglycerides) between baseline and 6-month follow-up

  Baseline and 6-month follow-up

• Changes in hand grip strength between baseline and 6-month follow-up

  Baseline and 6-month follow-up

• Changes in systolic/diastolic blood pressure between baseline and 6-month follow-up

  Baseline and 6-month follow-up

• Changes in Self-reported Physical Activity between baseline and Immediate post-intervention, between baseline and 12-month post-intervention, and between baseline and 6-month follow-up

  Baseline, Immediate post-intervention, 12-month post-intervention, 6-month follow-up

Study Arms (3)

Control Group

NO INTERVENTION

The control group will receive a Fitbit device

Intervention Group - Genetic Risk Estimate+health coaching

EXPERIMENTAL

Genetic: Genetic Risk Estimate The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' (if their genetic risk is higher than the average population risk) or 'no increased genetic risk' (if their genetic risk is not higher than the average population risk). Health coaching will be incorporated as well.

Genetic: Genetic Risk Estimate+Health Coaching; Device: Genetic Risk Estimate + Fitbit Functions+Health Coaching

Intervention Group - Genetic Risk Estimate + Fitbit Functions+health coaching

EXPERIMENTAL

Device: Genetic Risk Estimate + Fitbit Functions The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' or 'no increased genetic risk'. The two unique Fitbit functions are step goal setting and prompts. Individualized daily step goals will be set to be 10% higher than participants' own baseline Fitbit step counts. The 'Reminder To Move' function of Fitbit will be used as a prompt to remind participants to reduce sedentary time and walk at least 250 steps/hour within a specified timeframe (i.e., from 9am to 10pm in the proposed research). If the user has not accumulated at least 250 steps/hour, a reminder (for example, 150 steps to go) will appear on the Fitbit screen at 10 minutes before the hour (for example, at 10:50 a.m.) and cause the device to vibrate. Health coaching will be incorporated as well.

Device: Genetic Risk Estimate + Fitbit Functions+Health Coaching

Interventions

Genetic Risk Estimate+Health Coaching GENETIC

The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' (if their genetic risk is higher than the average population risk) or 'no increased genetic risk' (if their genetic risk is not higher than the average population risk). Health coaching will be incorporated through phone or Zoom calls to provide an explanation of each participant's own genetic risk of CHD as well as lifestyle modification measures.

Intervention Group - Genetic Risk Estimate+health coaching

Genetic Risk Estimate + Fitbit Functions+Health Coaching DEVICE

Intervention: Device: Genetic Risk Estimate + Fitbit Functions The genetic risk information includes individual remaining-lifetime and 10-year genetic risk estimates for CHD as well as a dichotomized genetic risk category: 'increased genetic risk' or 'no increased genetic risk'. The two unique Fitbit functions are step goal setting and prompts. Individualized daily step goals will be set to be 10% higher than participants' own baseline Fitbit step counts. The 'Reminder To Move' function of Fitbit will be used as a prompt to remind participants to reduce sedentary time and walk at least 250 steps/hour within a specified timeframe (i.e., from 9am to 10pm in the proposed research). If the user has not accumulated at least 250 steps/hour, a reminder (for example, 150 steps to go) will appear on the Fitbit screen at 10 minutes before the hour (for example, at 10:50 a.m.) and cause the device to vibrate. Health coaching will be incorporated as well

Intervention Group - Genetic Risk Estimate + Fitbit Functions+health coaching; Intervention Group - Genetic Risk Estimate+health coaching

Eligibility Criteria

• Age: 60 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• East Asian ancestry
• Do not meet the WHO-recommended levels of PA (i.e., ≥150 minutes/week of moderate-intensity PA, ≥75 minutes/week of vigorous-intensity PA, or an equivalent combination of the two; determined through the IPAQ-Short Form).

You may not qualify if:

• Previously diagnosed with CHD, and/or participation in another exercise-intervention study.

Sponsors & Collaborators

• The University of Hong Kong: lead

MeSH Terms

Conditions

Sedentary Behavior; Genetic Predisposition to Disease; Coronary Disease

Condition Hierarchy (Ancestors)

Behavior; Disease Susceptibility; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases

Study Officials

• Youngwon Kim, Dr

  The University of Hong Kong

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Youngwon Kim, Dr

CONTACT

(+852)28315252; youngwon.kim@hku.hk

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, INVESTIGATOR
• Masking Details: Staff without knowledge of participant information will create a computer-generated list that consists of blocks of six that contain two of each of the three groups per block in a random order. The randomisation list will be incorporated into a computer program that our staff will use for enrolment and automated random assignment of participants. Group allocation will be concealed from study staff until the 7-day pre-intervention period begins (to allow preparation of genetic risk estimates and/or calculate Fitbit step goals from baseline data) and concealed from participants until the intervention begins. Given the nature of the interventions, it is impossible for participants to be blinded to their group allocation; however, research staff analysing participants' deidentified data will remain blinded to participant group assignments.
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Model Details: parallel-group, open randomized controlled trial

Study Record Dates

• First Submitted: March 16, 2023
• First Posted: March 29, 2023
• Study Start: January 1, 2024
• Primary Completion: January 1, 2026
• Study Completion (Estimated): June 1, 2026
• Last Updated: March 29, 2023

Record last verified: 2023-03